Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125893851 | 12589385 | 1 | I | 201604 | 20160712 | 20160725 | 20160725 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-45744BP | BOEHRINGER INGELHEIM | 72.79 | YR | M | Y | 0.00000 | 20160725 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125893851 | 12589385 | 1 | PS | FLOMAX | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.4 MG | 20579 | .4 | MG | CAPSULE | QD | ||||||
125893851 | 12589385 | 2 | C | COREG | CARVEDILOL | 1 | Oral | 12.5 MG | 0 | 6.25 | MG | TABLET | BID | ||||||
125893851 | 12589385 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 40 MG | 0 | 40 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125893851 | 12589385 | 1 | Nephrolithiasis |
125893851 | 12589385 | 2 | Cardiac disorder |
125893851 | 12589385 | 3 | Cardiac disorder |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125893851 | 12589385 | Hypotension | |
125893851 | 12589385 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125893851 | 12589385 | 1 | 201604 | 0 |